RESUMEN
The permanent therapeutic importance of morphine derivatives in pain treatment has inspired continual synthetic efforts to modify the rigid pentacyclic systems in search for new selective analgesic agents. As a result, several morphinane oximes have been synthesized recently, which have the additional advantage of possessing an oxime group that can provide a method for selective determination of opiate alkaloids in biological matrices. The oximes of hydrocodone and oxycodone have stronger analgesic effect than the parent ketones and they also proved to be effective in preventing the respiratory depressant and hypotensive actions of fentanyl. In this work a review is given on the present status of oxime pharmacology, chemistry and analysis and also the oxime and O-methyl oxime formation of 6-oxo-morphinanes with therapeutic interest (codeinone, oxycodone, hydrocodone and 14-OH-codeinone). The oxime formation was monitored by reversed-phase HPLC and the chromatographic properties of oxime isomers have been characterized. The assignation of the individual isomers isolated by preparative HPLC was performed by (1)H NMR spectroscopy based on the chemical shift differences of the 5-H signals. In this way the isomeric ratio in the oxime products could also be determined. It was found that in the case of Delta(7)-6-oxo-morphinanes, depending on the substituents, the formation of the Z-isomer highly dominates (73-96%) over that of the E-isomer. However, for the saturated 7,8-(dihydro) derivatives the E-isomer is definitely preferred (>98%). In conclusion of a survey on the theoretical background of oxime isomerism, the conformational differences between the saturated and unsaturated morphinane systems were found responsible for the different E/Z ratios. On the basis of the isomeric ratio and the on-line CD and UV spectra of the pure isomers, the molar ellipticities and absorbancies of the isomers were calculated by a parameter estimation method.
Asunto(s)
Morfina/análisis , Morfina/química , Oximas/análisis , Oximas/química , Cromatografía Líquida de Alta Presión/métodos , Morfinanos/análisis , Morfinanos/química , Morfinanos/farmacología , Morfina/farmacología , Oximas/farmacologíaRESUMEN
Selective muscarinic agonists could be useful in the treatment of neurological disorders such as Alzheimer's disease, schizophrenia, and chronic pain. Many muscarinic agonists have been developed, yet most exhibit at best limited functional selectivity for a given receptor subtype perhaps because of the high degree of sequence homology within the putative binding site, which appears to be buried within the transmembrane domains. Bivalent compounds containing essentially two agonist pharmacophores within the same molecule were synthesized and tested for receptor binding affinity and muscarinic agonist activity. A series of bis-1,2,5-thiadiazole derivatives of 1,2,5,6-tetrahydropyridine linked by an alkyloxy moiety exhibited very high affinity (K(i) < 1 nM) and strong agonist activity. The degree of activity depended on the length of the linking alkyl group, which could be replaced by a poly(ethylene glycol) moiety, resulting in improved water solubility, binding affinity, and agonist potency.
Asunto(s)
Agonistas Muscarínicos/síntesis química , Piridinas/síntesis química , Tiadiazoles/síntesis química , Unión Competitiva , Línea Celular , Diseño de Fármacos , Humanos , Ligandos , Modelos Moleculares , Agonistas Muscarínicos/química , Agonistas Muscarínicos/farmacología , Fosfatidilinositoles/metabolismo , Estructura Terciaria de Proteína , Piridinas/química , Piridinas/farmacología , Ensayo de Unión Radioligante , Receptor Muscarínico M1 , Receptor Muscarínico M3 , Receptor Muscarínico M5 , Receptores Muscarínicos/metabolismo , Solubilidad , Relación Estructura-Actividad , Tiadiazoles/química , Tiadiazoles/farmacología , TransfecciónRESUMEN
Comparison of the kinetics of the inward Ca(2+) ion flux to (S)-alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid [(S)-AMPA] in cerebrocortical homogenates and that of the previously reported transmembrane Na(+) ion influx mediated by an AMPA receptor in hippocampal homogenates established that the agonist-induced opening of the AMPA receptor channels occurs in two kinetically distinguishable phases. Here we report that the 2-methyl-4-oxo-3H-quinazoline-3-acetic acid (Q1) inhibits the major slow-phase response specifically, whereas the acetyl piperidine derivative (Q5) is a more potent inhibitor of the fast-phase response. Both the quinazolone-3-propionic acid (Q2) and the quinazolone-3-acetic acid methyl ester (Q3) enhanced the slow-phase response to (S)-AMPA. The information provided by docking different Q1, Q2, and Q5 models at the ligand-binding core of iGluRs were used to define agonistic and antagonistic modes of interactions. Based on the effects of quinazolone-3-alkyl-carboxylic acid derivatives on specific [(3)H]Glu binding and kinetically distinguishable Ca(2+) ion permeability responses to (S)-AMPA and molecular modeling, the fast- and the slow-phase (S)-AMPA-elicited Ca(2+) ion fluxes were corresponded to different subunit compositions and degrees of S1S2 bridging interaction relative to substitution of kainate thereupon. Substitutions of agonists and antagonists into the iGluR2 S1S2 ligand binding core induced different modes of domain-domain bridging.
Asunto(s)
Canales de Calcio/efectos de los fármacos , Calcio/metabolismo , Membrana Celular/metabolismo , Fármacos actuantes sobre Aminoácidos Excitadores/farmacología , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiónico/metabolismo , Acetatos/química , Acetatos/metabolismo , Acetatos/farmacología , Animales , Sitios de Unión , Corteza Cerebral/química , Fármacos actuantes sobre Aminoácidos Excitadores/química , Fármacos actuantes sobre Aminoácidos Excitadores/metabolismo , Agonistas de Aminoácidos Excitadores/química , Agonistas de Aminoácidos Excitadores/metabolismo , Antagonistas de Aminoácidos Excitadores/química , Antagonistas de Aminoácidos Excitadores/metabolismo , Ácido Glutámico/química , Ácido Glutámico/metabolismo , Activación del Canal Iónico/efectos de los fármacos , Ligandos , Masculino , Modelos Moleculares , Estructura Molecular , Piperidinas/química , Piperidinas/metabolismo , Piperidinas/farmacología , Propionatos/química , Propionatos/metabolismo , Propionatos/farmacología , Quinazolinas/química , Quinazolinas/metabolismo , Quinazolinas/farmacología , Ratas , Ratas Wistar , Receptores AMPA/química , Receptores AMPA/metabolismo , Relación Estructura-Actividad , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiónico/químicaRESUMEN
Cholinergic neurons degenerate in Alzheimer's disease, resulting in cognitive impairments and memory deficits, and drug development efforts have focused on selective M1 muscarinic agonists. 5-(3-Ethyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine trifluoroacetic acid (CDD-0102) stimulates M1 muscarinic receptors in rat brain [Messer, W.S., Jr., Abuh, Y.F., Liu, Y., Periyasamy, S., Ngur, D.O., Edgar, M.A., El-Assadi, A.A., Sbeih, S., Dunbar, P.G., Roknich, S., Rho, T., Fang, Z., Ojo, B., Zhang, H., Huzl, J.J., III, Nagy, P.I., 1997a. J. Med. Chem. 40, 1230-1246.] and improves memory function in rats with lesions of the basal forebrain cholinergic system. Moreover, CDD-0102 exhibits oral bioavailability, few side effects and low toxicity, and thus represents a viable candidate for clinical studies. Despite the development of functionally selective agonists such as xanomeline and CDD-0102, there is room for improvements in ligand affinity and selectivity. The high degree of amino acid homology within transmembrane domains has hindered the development of truly selective agonists. Site-directed mutagenesis, biochemical and molecular modeling studies have identified key amino acid residues such as Thr192 and Asn382 in the binding of agonist to M1 receptors [Huang, X.P., Nagy, P.I., Williams, F.E., Peseckis, S.M., Messer, W.S., Jr., 1999. Br. J. Pharmacol. 126, 735-745.]. Recent work has implicated residues at the top of transmembrane domain VI in the binding of muscarinic agonists and activation of M1 receptors [Huang, X.P., Williams, F.E., Peseckis, S.M., Messer, W.S., Jr., 1998. J. Pharmacol. Exp. Ther. 286, 1129-1139.]. Thus, residues such as Ser388 represent molecular targets for the further development of agonists with improved M1 receptor affinity, selectivity and activity.
Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Agonistas Muscarínicos/síntesis química , Piridinas/síntesis química , Receptores Muscarínicos/efectos de los fármacos , Tiadiazoles/síntesis química , Enfermedad de Alzheimer/genética , Animales , Diseño de Fármacos , Inyecciones Intraperitoneales , Ligandos , Masculino , Modelos Moleculares , Agonistas Muscarínicos/farmacología , Agonistas Muscarínicos/uso terapéutico , Mutagénesis Sitio-Dirigida , Piridinas/farmacología , Piridinas/uso terapéutico , Ratas , Ratas Sprague-Dawley , Receptor Muscarínico M1 , Receptores Muscarínicos/química , Receptores Muscarínicos/genética , Tiadiazoles/farmacología , Tiadiazoles/uso terapéuticoRESUMEN
Conserved amino acids, such as Thr in transmembrane domains (TM) V and Asn in TM VI of muscarinic receptors, may be important in agonist binding and/or receptor activation. In order to determine the functional roles of Thr192 and Asn382 in human M1 receptors in ligand binding and receptor activation processes, we created and characterized mutant receptors with Thr192 or Asn382 substituted by Ala. HM1 wild-type (WT) and mutant receptors [HM1(Thr192Ala) and HM1(Asn382Ala)] were stably expressed in A9 L cells. The Kd values for 3H-(R)-QNB and Ki values for other classical muscarinic antagonists were similar at HM1(WT) and HM1(Thr192Ala) mutant receptors, yet higher at HM1(Asn382Ala) mutant receptors. Carbachol exhibited lower potency and efficacy in stimulating PI hydrolysis via HM1(Thr192Ala) mutant receptors, and intermediate agonist activity at the HM1(Asn382Ala) mutant receptors. The Asn382 residue in TM VI but not the Thr192 residue in TM V of the human M1 receptor appears to participate directly in antagonist binding. Both Thr192 and Asn382 residues are involved differentially in agonist binding and/or receptor activation processes, yet the Asn382 residue is less important than Thr192 in agonist activation of M1 receptors. Molecular modelling studies indicate that substitution of Thr192 or Asn382 results in the loss of hydrogen-bond interactions and changes in the agonist binding mode associated with an increase in hydrophobic interactions between ligand and receptor.
Asunto(s)
Asparagina/fisiología , Agonistas Muscarínicos/farmacología , Antagonistas Muscarínicos/farmacología , Receptores Muscarínicos/efectos de los fármacos , Treonina/fisiología , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Animales , Asparagina/química , Sitios de Unión , Unión Competitiva , Células CHO , Línea Celular , Cricetinae , Humanos , Modelos Moleculares , Agonistas Muscarínicos/química , Agonistas Muscarínicos/metabolismo , Antagonistas Muscarínicos/química , Antagonistas Muscarínicos/metabolismo , Fosfatidilinositoles/metabolismo , Pirenzepina/farmacología , Quinuclidinil Bencilato/metabolismo , Ensayo de Unión Radioligante , Receptor Muscarínico M1 , Receptores Muscarínicos/química , Receptores Muscarínicos/metabolismo , Escopolamina/farmacología , Treonina/química , TritioRESUMEN
In the present investigation, the rationale for the design, synthesis, and biological evaluation of potent inhibitors of neuronal Na+ channels is described. N,N'-diaryl- and N-aryl-N-aralkylguanidine templates were locked in conformations mimicking the permissible conformations of the flexible diarylguanidinium ion (AS+, AA+, SS+). The resulting set of constrained guanidines termed "lockamers" (cyclophane, quinazoline, aminopyrimidazolines, aminoimidazolines, azocino- and tetrahydroquinolinocarboximidamides) was examined for neuronal Na+ channel blockade properties. Inhibition of [14C]guanidinium ion influx in CHO cells expressing type IIA Na+ channels showed that the aminopyrimidazoline 9b and aminoimidazoline 9d, compounds proposed to lock the N,N'-diarylguanidinium in an SS+ conformation, were the most potent Na+ channel blockers with IC50's of 0.06 microM, a value 17 times lower than that of the parent flexible compound 18d. The rest of the restricted analogues with 4-p-alkyl substituents retained potency with IC50 values ranging between 0.46 and 2.9 microM. Evaluation in a synaptosomal 45Ca2+ influx assay showed that 9b did not exhibit high selectivity for neuronal Na+ vs Ca2+ channels. The retention of significant neuronal Na+ blockade in all types of semirigid conformers gives evidence for a multiple mode of binding in this class of compounds and can possibly be attributed to a poor structural specificity of the site(s) of action. Compound 9b was also found to be the most active compound in vivo based on the high level of inhibition of seizures exhibited in the DBA/2 mouse model. The pKa value of 9b indicates that 9b binds to the channel in its protonated form, and log D vs pH measurements suggest that ion-pair partitioning contributes to membrane transport. This compound stands out as an interesting lead for further development of neurotherapeutic agents.
Asunto(s)
Diseño de Fármacos , Imidazoles , Neuronas/efectos de los fármacos , Pirimidinas , Bloqueadores de los Canales de Sodio , Animales , Anticonvulsivantes/síntesis química , Anticonvulsivantes/química , Anticonvulsivantes/metabolismo , Anticonvulsivantes/farmacología , Transporte Biológico , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/ultraestructura , Células CHO , Calcio/metabolismo , Bloqueadores de los Canales de Calcio/síntesis química , Bloqueadores de los Canales de Calcio/química , Bloqueadores de los Canales de Calcio/metabolismo , Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio/efectos de los fármacos , Cricetinae , Femenino , Guanidina/metabolismo , Imidazoles/síntesis química , Imidazoles/química , Imidazoles/metabolismo , Imidazoles/farmacología , Masculino , Ratones , Ratones Endogámicos DBA , Conformación Molecular , Neuronas/metabolismo , Pirimidinas/síntesis química , Pirimidinas/química , Pirimidinas/metabolismo , Pirimidinas/farmacología , Ratas , Receptores de N-Metil-D-Aspartato/metabolismo , Convulsiones/prevención & control , Canales de Sodio/biosíntesis , Relación Estructura-Actividad , Sinaptosomas/efectos de los fármacos , Sinaptosomas/metabolismoRESUMEN
Previous studies identified several novel tetrahydropyrimidine derivatives exhibiting muscarinic agonist activity in rat brain. Such compounds might be useful in treating cognitive and memory deficits associated with low acetylcholine levels, as found in Alzheimer's disease. To determine the molecular features of ligands important for binding and activity at muscarinic receptor subtypes, the series of tetrahydropyrimidines was extended. Several active compounds were examined further for functional selectivity through biochemical studies of muscarinic receptor activity using receptor subtypes expressed in cell lines. Several amidine derivatives displayed high efficacy at m1 receptors and lower activity at m3 receptors coupled to phosphoinositide (PI) metabolism in A9 L cells. Four ligands, including 1b, 1f, 2b, and 7b, exhibited marked functional selectivity for m1 vs m3 receptors. Compound 1f also exhibited low activity at m2 receptors coupled to the inhibition of adenylyl cyclase in A9 L cells. Molecular modeling studies also were initiated to help understand the nature of the interaction of muscarinic agonists with the m1 receptor using a nine amino model of the m1 receptor. Several important interactions were identified, including interactions between the ester moiety and Thr192. Additional interactions were found for oxadiazoles and alkynyl derivatives with Asn382, suggesting that enhanced potency and selectivity may be achieved by maximizing interactions with Asp105, Thr192, and Asn382. Taken together, the data indicate that several amidine derivatives display functional selectivity for m1 muscarinic receptors, warranting further evaluation as therapeutic agents for the treatment of Alzheimer's disease. In addition, several amino acid residues were identified as potential binding sites for m1 agonists. These data may be useful in directing efforts to develop even more selective m1 agonists.
Asunto(s)
Agonistas Muscarínicos/síntesis química , Pirimidinas/química , Receptores Muscarínicos/metabolismo , Animales , Arecolina/farmacología , Encéfalo/metabolismo , Carbacol/farmacología , Línea Celular , Modelos Moleculares , Agonistas Muscarínicos/química , Agonistas Muscarínicos/metabolismo , Fosfatidilinositoles/metabolismo , Pirimidinas/síntesis química , Pirimidinas/metabolismo , Quinuclidinil Bencilato/metabolismo , Ratas , Receptor Muscarínico M1 , Receptor Muscarínico M2 , Receptor Muscarínico M3 , Relación Estructura-ActividadRESUMEN
As part of a continuing effort aimed at the development of selective, efficacious, and centrally active m1 muscarinic agonists for the treatment of Alzheimer's disease, a series of amide and hydrazide amidine derivatives (2a-e and 3b-d) was synthesized and examined for muscarinic agonist activity. Preliminary biochemical studies indicated that 2b, 2d, and 3d bound to muscarinic receptors in rat brain and stimulated phosphoinositide (PI) metabolism in rat cerebral cortex. Compounds 2b and 2d were also highly efficacious at m1 muscarinic receptors expressed in cultured A9 L cells. Molecular modeling studies suggest slightly different modes of interaction with m1 receptors for the ester and amide derivatives. Also, hydrogen-bond formation with a Thr residue may be important for m1 muscarinic agonist potency. The data suggest that the amide moiety can replace the ester group found in muscarinic agonists and provide further support for the utility of amidine derivatives in the development of efficacious m1 agonists.
Asunto(s)
Amidinas/química , Receptores Muscarínicos/metabolismo , Amidinas/metabolismo , Animales , Encéfalo/metabolismo , Línea Celular , Cinética , Modelos Moleculares , Quinuclidinil Bencilato/metabolismo , Ratas , Receptor Muscarínico M1RESUMEN
Efetuaram-se simulacoes de dinamica molecular a 298 K, usando o programa MOLSIM, para o tridecamero peptidico modelo da proteina aderente do mexilhao Mytilus edulis L. Os resultados estruturais sao comparados aos obtidos com o uso de tecnicas de mecanica molecular e de minimizacao de energia. O tridecamero adota estrutura de dupla volta reversa para as sequencias Lys-Pro-Ser-Tyr e Hyp-Hyp-Thr-Dopa. Na primeira volta, encontrou-se estrutura beta em mais que 50 porcento das simulacoes. Para as trajetorias remanescentes, adotou-se geralmente uma volta gama, composta de residuos de Lys-Pro-Ser. A segunda volta e uma volta beta, que e conservada atraves de simulacoes utilizando modelos e temperaturas diferentes. As duas voltas adjacentes garantem estrutura globular para o modelo da proteina, que e mantida em faixas de constantes dieletricas moleculares entre 1 e 15. Encontrou-se uma conformacao estendida como sendo uma conformacao secundaria, de energia maior em 40-90 kcal tridecamero. Identificaram-se diversas ligacoes de hidrogenio, que mantem a volta dupla estavel. A maioria dessas ligacoes de hidrogenio compreende um grupo OH, que pode explicar a porcentagem extraordinariamente alta de residuos contendo OH, especialmente Hyp e Dopa. A conformacao do modelo de proteina incorpora cadeias laterais de Lys, Dopa e Tyr, que apresentam as funcoes polares proximas umas das outras. Esse arranjo favorece uma geometria de ligacao cruzada na proteina, proposta a partir dos resultados experimentais com a placa aderente
Asunto(s)
Modelos Moleculares , Estructura Molecular , Mytilus edulis , Péptidos/biosíntesis , Proteínas/biosíntesis , Conformación ProteicaRESUMEN
Conformational analyses of three families of substituted dichlorodiphenyl aromatase inhibitors indicated that both potent and weak inhibitors adopt a common global minimum energy conformation. Further, this global minimum energy conformation is the only meaningful intramolecular conformer state that can be energetically realized and is virtually identical to the crystal structure of one of the analogs. Quantitative structure-activity relationships, QSARs, were separately, and jointly, developed for two series of inhibitors. The distance, D, of a nitrogen atom in the variable heterocycle from the core Cc atom is the most important activity descriptor. The optimum distance between the nitrogen and Cc to maximize inhibitor potency is about 3.6 A for both classes of analogs. Integrated potential energy field difference calculations were also carried out using a proton probe and some of the variable heterocycles. The field calculations coupled with the QSAR studies suggest that the nitrogen 3.6 A from Cc acts as a hydrogen bond acceptor. Two possible three-dimensional pharmacophores are proposed for effective aromatase inhibitors.
Asunto(s)
Inhibidores de la Aromatasa , Metano/análogos & derivados , Metanol/análogos & derivados , Enlace de Hidrógeno , Metano/química , Metano/farmacología , Metanol/química , Metanol/farmacología , Conformación Molecular , Estructura Molecular , Nitrógeno/química , Relación Estructura-Actividad , TermodinámicaRESUMEN
Conformations of model peptides of the adhesive protein of the mussel, Mytilus edulis L were investigated using molecular mechanics. The protein structure was represented as the repeat of a 10-residue unit. This decamer, and di- and tri-decamers of it, were considered in the modeling. Incorporation of the unusual dopamine residue in the decamer repeat may be explained by its hydrogen bond forming ability via its 3-OH group to a proline carbonyl oxygen. This bond contributes to maintaining a double reverse beta-turn structure in the decamer. This conformation was found more stable than 3(1) and alpha helical conformations. Adjacent reverse beta-turn structures are connected by short segments (2 to 3 residues) having little conformational preference. Thus, the overall protein can possess a significant random nature, yet have a highly ordered embedded conformational component. Hydrophilic character is in line with the larger number of OH groups on the phenyl ring for residue 9 (the site of the Dopa residue). The dehydration free energy of the (3-OH)-Phe as compared to the Dopa derivative is less by 1.4 kcal per decamer unit. This amounts to more than 100 kcal energy gain in the dehydration process for the total protein.